surmount-1 tirzepatide trial obesity without diabetes non-diabetic weight loss Nutritional status with in obesity: A post hoc analysis of the SURMOUNT-1-4 randomized clinical trials surmount-1 tirzepatide trial obesity – Effect of tirzepatide in SURMOUNT-1

B12 is an essential vitamin that supports energy production and nervous system health

A standard multivitamin and mineral supplement providing approximately 100% of reference nutrient intakes may offer a practical foundation for patients with confirmed poor dietary intake, though individual needs should be assessed based on dietary patterns, symptoms, and blood test results where clinically indicated

Anti-cytochrome c (Cat No: 21680) was obtained from Signalway Antibody (Maryland, USA)

Injectable semaglutide 2.4 mg (Wegovy) produces somewhat greater weight loss than orforglipron: approximately 14.9% at 68 weeks in the STEP 1 trial versus 11.2% at 72 weeks with orforglipron 36 mg in ATTAIN-1

At the same time, vitamin C contributes to protecting cells against oxidative stress and to the normal functioning of the immune system, complementing the action of carnitine

Regular screening and education are essential components of comprehensive care